1. Home
  2. INBS

as of 12-12-2025 3:33pm EST

$0.56
$0.16
-22.70%
Stocks Health Care Medical Specialities Nasdaq

Intelligent Bio Solutions Inc is a life sciences company developing non-invasive, real-time monitoring and diagnostic tests for patients and their primary health practitioners. Its Biosensor Platform is developing and launching diagnostic tests urgently needed to help people living with chronic diseases. It also engages in the advancement of portable drug abuse testing through the analysis of fingerprint sweat. The test is non-invasive, hygienic, and fast, and screens for recent use of opioids, cocaine, methamphetamines, benzodiazepines, and marijuana. The company operates through new reportable segments: United Kingdom; Asia Pacific (APAC); Americas; and Rest of World, of which United Kingdom derives maximum revenue.

Chart Type:
Time Range:
Founded: 2016 Country:
United States
United States
Employees: 55 City: NEW YORK
Market Cap: 5.3M IPO Year: N/A
Target Price: N/A AVG Volume (30 days): 148.5K
Analyst Decision: N/A Number of Analysts: N/A
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -1.68 EPS Growth: N/A
52 Week Low/High: $0.56 - $2.75 Next Earning Date: 11-12-2025
Revenue: $3,292,042 Revenue Growth: 3.26%
Revenue Growth (this year): 778.48% Revenue Growth (next year): N/A

AI-Powered INBS Daily Prediction

Machine learning model trained on 25+ technical indicators

Updated 4 days ago

AI Recommendation

hold
Model Accuracy: 71.53%
71.53%
Confidence

Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.

Latest Intelligent Bio Solutions Inc. News

INBS Breaking Stock News: Dive into INBS Ticker-Specific Updates for Smart Investing

All INBS News

Share on Social Networks: